Minnesota shuns federal COVID-19 vaccine guidance
Digest more
Trump links autism to Tylenol, vaccines
Digest more
The group voted to make people who want a COVID shot to be briefed on harms and benefits, but in a close vote, it failed to pass a proposal that states should require people to get a prescription.
Only people 65 and over or with underlying health conditions should get the shots, the advisory group recommended. There may be insurance roadblocks for others.
28mon MSN
Despite escalating anti-vaccine rhetoric, most Americans support vaccine mandates, surveys find
An April 2025 survey found that 70% of the public believes children should be required to receive the MMR vaccine before attending public school.
Illinois Gov. JB Pritkzer said the state is "stepping up" as he slams federal government for new vaccine guidelines.
In an email, the HHS spokesperson defended Kennedy’s ACIP, writing that the committee “is guided by gold standard science and will make any recommendations based on the totality of evidence presented to them. HHS has not, and will not, limit access to vaccines.”
A panel of new vaccine advisers picked by Health Secretary Robert F. Kennedy Jr. voted Friday to end the Centers for Disease Control and Prevention’s universal recommendation that people of all ages get Covid shots,
WASHINGTON — President Trump on Monday suggested an overhaul to how children get vaccinated after claiming, without evidence, that many vaccines are unsafe as currently given. The president said he has talked with health secretary Robert F. Kennedy Jr. about his proposed changes.
RFK Jr.’s panel recommended halting MMRV vaccines for children under four and postponed voting on the hepatitis B schedule.
The Advisory Committee on Immunization Practices, called ACIP, on Friday voted to abandon its recommendation for the COVID-19 vaccine.
Private health insurers in the state will continue to cover routine shots despite potential changes in federal recommendations, he says.
Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups Clinical findings reinforce preclinical data supporting recent FDA approval of 2025-2026 formula of Spikevax CAMBRIDGE,
Feedback